Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal dexmedetomidine for postoperative pain after elective cesarean section
IRCT20260216068880N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Postoperative pain severity based on Visual Analog Scale. Started Apr 2026; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20260216068880N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260216068880N1.